Investment by Philip Morris in a Cannabis Technology Company is a Game Changer for the Industry

Last February I was asked by USA Today whether I thought that the cigarette industry was investing in the cannabis industry. My comment at the time was that I thought that cigarette manufacturers wouldn’t go anywhere near the plant until it was legal in the U.S. at the federal level.

Almost one year has passed, and the cigarette giant, Philip Morris International has announced that it will invest $20 million in a medical cannabis technology company. The investment was not in a U.S. company, but instead, in Syqe Medical, an early-stage Israeli company.  

Syqe Medical has developed a metered-dose inhaler that allows medical cannabis to be delivered in a safe and precise manner. The Company’s technology turns cannabis into a granulate and allows it to be taken in metered doses.

While the official announcement indicated that “Syqe Medical will develop technologies for Philip Morris that will help reduce health...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.